Animal Health Market Size Hit $ 119.57Bn, Globally, by 2027 Growing at 6.3% CAGR | Exclusive Report by The Insight Partners

The global animal health market is expected to reach US$ 119.57099 billion by 2027 from US$ 73.79833 billion in 2019. The market is estimated to grow at a CAGR of 6.3% from 2020 to 2027.

New York, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on ‘Animal Health Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Product, and Animal Type,’ the report highlights the trends prevalent in the global animal health market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due increasing incidences of zoonotic diseases, rise in demand for proteinaceous food, and initiatives by governments and animal welfare associations. However, the use of counterfeit medicines, and high complexity and cost of animal drug development and approval processes are likely to restrain the market growth during the forecast period.

Get Sample PDF Copy of Animal Health Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at:

Animal Health Market Report Scope & Strategic Insights:

Report CoverageDetails
Market Size Value inUS$ 73.79833 Billion in 2019
Market Size Value byUS$ 119.57099 Billion by 2027
Growth rateCAGR of 6.3% from 2020 to 2027.
Forecast Period2020-2027
Base Year2020
No. of Pages195
No. Tables95
No. of Charts & Figures69
Historical data availableYes
Segments coveredProduct and Animal Type
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends

Animal Health Market: Competitive Landscape and Key Developments

Merck & Co., Inc; Boehringer Ingelheim International GmbH; Ceva Santé Animale; Cargill, Incorporated; Zoetis Inc.; Bayer AG; Vetoquinol SA; Nutreco N.V; Virbac; and Elanco are among the leading companies in the global animal health market. Several companies are implementing organic strategies, such as products launch and expansions.

  • In March 2020, Bayer AG launched Care4Pigs initiative in collaboration with the Farm Animal Welfare Education Centre (FAWEC) and the Korean Association of Swine Veterinarians (KASV). Under the collaboration, US$ 11,037 were granted to support innovation aimed at enhancing swine well-being.
  • In February 2020, Zoetis Inc. acquired the Diagnostic Science, a veterinary reference lab business. The acquisition enabled the company to strengthen its service portfolio.
  • In February, 2020, Vetoquinol SA announced the acquisition of Profender and Drontal product families from Elanco Animal Health. It will also acquire intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
  • In November 2019, Zoetis Inc. acquired ZNLabs, a full-service veterinary clinical reference laboratory company that has a wide network of labs across the US.
  • In November 2019, Cargill, Incorporatedhas expanded its Animal Nutrition & Health facility in Temple, Texas. It invested US$ Mn to build the manufacturing, packaging, warehousing, and shipping capabilities center. The facility centers will serve Cargill’s farm and ranch feed store owners and beef feed, customers. It will serve through reduced transportation costs for local customers and also, it has increased manufacturing capabilities.
  • In September 2018, Boehringer Ingelheim International GmbH launched Semintra 10 mg/ml Oral Solution, to treat feline hypertension in cats. The medicine was available in selected European countries.

Inquiry Before Purchase:

Increasing Incidences of Zoonotic Diseases to Drive Animal Health Market

Animals can act as carriers of harmful bacteria, viruses, parasites, and fungi to humans, leading to illness, which are referred as zoonotic diseases or zoonoses. The clinical effect of zoonotic illnesses may range from mild to severe, and might sometimes lead to death. Zoonotic diseases are prevalent in the world. As per the estimates of the Center for Disease Control (CDC), 3 out of every 4 new or upcoming infectious diseases in people comes from animals. In the past decades, many previously unknown infectious human diseases, such as Ebola virus, Human Immunodeficiency Virus (HIV), Nipah virus, West Nile virus, and Hantavirus infections, have emerged from animal reservoirs. Outbreaks such as severe acute respiratory syndrome (SARS) and avian influenza have reminded the potential of microorganisms from animal reservoirs to adapt to human hosts. More than three-quarters of the human diseases that are new, emerging, or re-emerging at the beginning of the 21st century are caused by pathogens that are originated from animals or products of animal origin. According to the WHO, about 1 billion cases of illness and millions of death occur from zoonoses. Hence, emerging and re-emerging of zoonotic diseases have become a significant factor raising the demand for animal health, and this has triggered companies to produce advanced pharmaceuticals and vaccines to help animal owners or other stakeholders to maintain the overall health of animals.

Increased urbanization and changes in lifestyle alter patterns of food consumption and are the major factors leading to the increase in meat and milk consumption, globally. Livestock products have emerged as a primary source of dietary proteins. With population growth and elevated living standards, rapid growth in the consumption of animal products has forced the livestock industry to adapt to this change and meet the expectations of society with improved-quality products. In addition, in South Asia, there has been a slow, but steady growth in the consumption of animal products, predominantly milk and poultry meat, while in East Asia, pork is the predominant product consumed. However, in China, the consumption of poultry meat and eggs has increased in the last decade. As per Our World in Data, the global demand for meat is growing: over the past 50 years, meat production has more than quadrupled. The world now produces more than 320 million tonnes of meat each year. Moreover, to fulfill the demand for protein-rich food, such as eggs, milk, and meat, the global emphasis has shifted over increasing the production of farm animals. However, due to the mounted risk of transfer of animal diseases to humans, the need for animal healthcare products has also surged at the global level.

Have a question? Speak to Research Analyst:

At present, the veterinary healthcare market is receiving significant improvement from initiatives led by the animal welfare association’s governments and of several countries, globally. To increase the adoption of animal health services, governments directly get involved in activities raising awareness regarding animal diseases, along promoting the privatization of animal healthcare services. In Europe, the Livestock Insurance scheme was implemented to increase the efficiency and effectiveness of animal healthcare systems. Moreover, the World Organization for Animal Health (OIE) is the intergovernmental organization in charge of improving animal health worldwide. In the UK, the Cattle Health and Welfare Group (CHAWG) addresses important cattle health and welfare issues; however, in the US, at associations such as Winter Haven, veterinary healthcare associates support the human–animal bond and provide high-quality services for any situation. Similarly, the 2020 Healthy Pets Healthy Families Initiative (HPHF) was launched by the Veterinary Public Health Program (VPH) at the Los Angeles County Department of Public Health to develop both animal and human health.

For instance, in March 2020, Bayer AG announced the launch of Care4Pigs initiative; this was launched in collaboration with the Farm Animal Welfare Education Centre (FAWEC) and the Korean Association of Swine Veterinarians (KASV). Under the collaboration, EUR 10,000 are granted to support innovation aimed at enhancing the well-being of swine.

Avail Lucrative DISCOUNTS on “Animal Health Market” Research Study:

Animal Health Market: Segmental Overview

The animal health market, based on product, is segmented into prescription and non-prescription. The prescription segment is further segmented into vaccines, pharmaceuticals, feed additives, and diagnostics. Whereas the non-prescription is subsegmented into parasiticides, grooming products, and nutrition/supplements. The prescription segment held a larger share of the market in 2019. However, the non-prescription segment is estimated to register a higher CAGR in the market during the forecast period.

The animal health market, based on animal type, is further segmented into animal and companion animal. The production animal segment held a larger share of the market in 2019. Whereas the companion animal segment is estimated to register a higher CAGR in the market during the forecast period.

Directly Purchase Premium Copy of Animal Health Market Growth Report at:

Browse Adjoining Reports:  

Animal Parasiticides Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Endoparasiticides, Ectoparasiticides, Endectocides); Animal Type (Dairy and Food Producing Animals and Pet Animals) and Geography

Animal Therapeutics and Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type(Animal Diagnostic Products and Animal Therapeutics product.); Animal Type(Companion animals, Cattle, Pigs, Poultry and Sheep)

Animal Genetics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product (Poultry, Porcine, Bovine, Canine, and Others), Genetic Material (Semen and Embryo), and Services (DNA Typing, Genetic Trait Tests, Genetic Disease Tests, and Others)

Animal Feed Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Form (Pellets, Crumbles, Mash, Others); Livestock (Poultry, Ruminants, Swine, Aquaculture, Others); and Geography

Companion Animal Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, and Others); Application (Bacteriology, Clinical Pathology, Virology, Parasitology, and Others); Animal Type (Dogs, Cats, Horses, and Others); End User (Diagnostic Laboratories, Veterinary Hospitals and Clinics, Research Institutes and Universities);and Geography

Companion Animal Vaccines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type ( Canine Vaccines, Feline Vaccines ); Technology ( Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines ) and Geography

Companion Animal Specialty Drugs Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product Type (Antibiotics Segment, Anti-inflammatory Products Segment, Parasiticides, Heartworm, Behavioral Products, Nutritional Products, Skin Care Products, Vaccines Product); Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores)

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi


Phone: +1-646-491-9876

Press Release: